ProCE Banner Activity

My Treatment Approach for Very Elderly Patients With Multiple Comorbidities and Relapsed Myeloma

Clinical Thought
With many different treatment options available for patients with R/R MM, choosing the best one can be difficult. Here is how I choose treatment for elderly patients with R/R MM.

Released: December 13, 2016

Expiration: December 12, 2017

No longer available for credit.

Share

Faculty

Suzanne Lentzsch

Suzanne Lentzsch, MD, PhD

Director, Multiple Myeloma and Amyloidosis Program
Associate Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Celgene

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Takeda Oncology

Faculty Disclosure

Primary Author

Suzanne Lentzsch, MD, PhD

Director, Multiple Myeloma and Amyloidosis Program
Associate Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

Suzanne Lentzsch, MD, PhD, has disclosed that she has received consulting fees from Bristol-Myers Squibb, Janssen, Novartis, and Takeda and funds for research support from Celgene.